{{Rsnum
|rsid=1367448
|Gene=WLS
|Chromosome=1
|position=68168241
|Orientation=minus
|GMAF=0.405
|Gene_s=GNG12-AS1,WLS
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 46.0 | 39.8 | 14.2
| HCB | 23.4 | 48.2 | 28.5
| JPT | 30.1 | 46.0 | 23.9
| YRI | 44.5 | 45.2 | 10.3
| ASW | 40.4 | 52.6 | 7.0
| CHB | 23.4 | 48.2 | 28.5
| CHD | 17.4 | 56.9 | 25.7
| GIH | 32.7 | 43.6 | 23.8
| LWK | 40.9 | 42.7 | 16.4
| MEX | 15.5 | 50.0 | 34.5
| MKK | 60.9 | 35.3 | 3.8
| TSI | 37.3 | 54.9 | 7.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=C
  |Pval=5E-6
  |OR=1.55
  |ORtxt=[1.212-1.993]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}